Homeopathic shot may shield cancer patients from chemo nerve pain
NCT ID NCT04715542
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a homeopathic remedy called Stibium metallicum praeparatum 6x can prevent or reduce nerve damage caused by the chemotherapy drug paclitaxel. The study will include 120 breast cancer patients who will receive either the remedy or a placebo injection three times a week during and for six weeks after chemotherapy. The goal is to see if this approach can reduce pain, tingling, and numbness, allowing patients to complete their cancer treatment without dose reductions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stibium metallicum praeparatum 6x (a homeopathic preparation of antimony)
- What this could lead to
- If it works, this could offer a way to prevent painful nerve damage from chemotherapy, helping patients complete their cancer treatment without dose reductions.
- What could go wrong
- This is a small, early-stage trial testing a homeopathic remedy, which has no proven biological mechanism. The effect may be no better than placebo, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acupuncture vs. sham needles: a test for chemo nerve damage
- Video analysis could personalize rehab for chemo nerve damage
- Brain training and nerve stretching could ease chemo nerve damage
- Acupuncture and exercise join forces against chemotherapy nerve pain
- New drug candidate AH-008 takes first step toward easing chemotherapy nerve pain
- Acupuncture needles take on Chemo's nerve damage